| 5-aza-dc-5-aza-20 | deoxycytidine |
| 4HPR | N-(4-hydroxyphenyl) retinamide |
| AC | Adenocarcinoma |
| AF | Activation function |
| AR | Androgen receptors |
| ARE | Androgen Responsive Elements |
| ATRA | All-trans retinoic acid |
| BA | Bile acid |
| BE | Barrett’s esophagus |
| BPDE | Benzo-[a]pyrene diol epoxide |
| CCM | Columnar cell metaplasia |
| CCK2 | Cholecystokinin 2 |
| CDDP | Cisplatin, cisplatinum, or cis-diamminedichloroplatinum (II) |
| COUP TF | Chicken ovalbumin upstream promoter transcription factor |
| COX-2 | Cyclooxygenase-2 |
| CRBP-1 | Cellular retinol-binding protein-1 |
| CTD | C-terminal domain |
| Da-Ea | Ethyl acetate extract of D. altaica |
| DBD | DNA-binding domain |
| DDP | Diamminedichloroplatinum |
| DFS | Disease-free survival |
| DHT | Dihydrotestosterone |
| DNMT1 | DNA (cytosine-5)-methyltransferase1 |
| DNMT3A | DNA (cytosine-5)-methyltransferase 3A |
| DPN | Diarylpropionitrile |
| E2 | 17β-estradiol |
| EAC | Esophageal adenocarcinoma |
| EC | Esophageal cancer |
| EGFR | Epidermal growth factor receptor |
| ER | Estrogen receptor |
| EREs | Estrogen response elements |
| ERK | Extracellular-signal regulated kinase |
| ERRs | Estrogen related receptors |
| ESCC | Esophageal squamous cell cancer |
| ESR | Estrogen receptor |
| FAK | Focal adhesion kinase |
| FBXO32 | F-Box Protein 32 |
| FDA | Food and drug administration |
| FGFR | Fibroblast growth factor receptors |
| FKBP5 | FK506-binding protein 5 |
| FU | Fluorouracil |
| FXR | Farnesoid X receptor |
| GCA | Gastric cardia adenocarcinoma |
| GERD | Gastroesophageal reflux disease |
| GRs | Glucocorticoid receptors |
| HGF | Hepatocyte growth factor |
| HMOX1 | Heme Oxygenase 1 |
| HREs | Hormone response elements |
| HSP90 | Heat shock protein 90 |
| IL-6 | Interleukin-6 |
| JNK | c-Jun N-terminal kinases |
| KLK3 | Kallikrein Related Peptidase 3 |
| LBD | Ligand binding domain |
| LCA | Lithocholic acid |
| LDH | Lactate dehydrogenase |
| LINE-1 | Long Interspersed Element-1 |
| LXRs | Liver X receptor |
| MAPK | Mitogen-activated protein kinase |
| MMP | Matrix metalloproteinase |
| MPP | Methyl-piperidinopyrazole |
| MRTF | Master Regulator Transcription Factors |
| NCoR | Nuclear receptor corepressor |
| NF-κB | Nuclear factor kappa B |
| NNK | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
| NQO | Nitroquinoline 1-oxide |
| NRs | Nuclear receptors |
| NR1H4 | Nuclear Receptor Subfamily 1 Group H Member 4 |
| NR4A1 | Nuclear receptor 4A1 |
| NTD | N-terminal domain |
| OS | Overall survival |
| PAR | Pregnane-activated receptor |
| PCNA | Proliferating cell nuclear antigen |
| PG | Prostaglandin |
| PGC-1 | PPAR coactivator-1 |
| PHTPP | 4-[2-Phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]phenol |
| PLIN2 | Perilipin 2 |
| PPAR | Peroxisome Proliferator Activated Receptor |
| PPRE | Peroxisome proliferator response element |
| PPT | 1,3,5-tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole |
| PRs | Progesterone receptors |
| PXR | Pregnane X receptor |
| RA | Retinoic acid |
| RAR | Retinoic acid receptor |
| RAREs | Retinoic acid receptor elements |
| RRIG1 | Retinoid receptor-induced gene-1 |
| RXR | Retinoid X receptor |
| SERMs | Selective estrogen receptor modulators |
| SCC | Squamous cell carcinoma |
| SIRT1 | Sirtulin 1 |
| SMRT | Silencing mediator of retinoic acid and thyroid hormone receptor |
| STAT3 | Signal Transducer and Activator of Transcription 3 |
| SXR | Steroid and xenobiotic receptor |
| TFs | Transcription factors |
| TGR5 | Takeda G protein-coupled receptor 5 |
| TIG1 | Tazarotene-induced gene-1 |
| TLRs | Toll-like receptors |
| TNM | Tumor nodes metastases |
| TR | Thyroid hormone receptor |
| TRO | Troglitazone |
| TZD | Thiazolidinedione |
| VDR | Vitamin D receptor |
| VDR | Vitamin D receptor elements |
| VEGFA | Vascular endothelial growth factor A |
| WNT5A | Wnt Family Member 5A |